Journals / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 3

Analysis of Retinal Vessel Density and Macular Flow Area in Diabetic and Healthy Participants Using Optical Coherence Tomography Angiography

Pages
220–225
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The mean values of BCVA and CMT were 0.42±0.32 and 0.86±0.17 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To inspect the macular flow area, superficial and deep retinal vessel density measurements of optical coherence tomography (OCT) angiography (OCTA) in diabetic patients and healthy subjects.
📊
Key Findings & Data:Methods: This retrospectively reviewed, and the cross-sectional study included 64 right eyes of 64 diabetic patients (Diabetic group) and 60 right eyes of 60 healthy (Control group) subjects.
💡
Conclusion & Impact:Results: The mean values of BCVA and CMT were 0.42±0.32 and 0.86±0.17 (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To inspect the macular flow area, superficial and deep retinal vessel density measurements of optical coherence tomography (OCT) angiography (OCTA) in diabetic patients and healthy subjects. Methods: This retrospectively reviewed, and the cross-sectional study included 64 right eyes of 64 diabetic patients (Diabetic group) and 60 right eyes of 60 healthy (Control group) subjects. The diabetic group included two subgroups of patients with proliferative diabetic retinopathy (PDR) and patients with non-proliferative diabetic retinopathy (NPDR). The groups and subgroups were compared in terms of the best- corrected visual acuity (BCVA), intraocular pressure and OCT/OCTA measurements, including central macular thickness (CMT, um), macular flow area (mm2), foveal and parafoveal vessel density (VD, %) in the superficial and deep retinal layers. Results: The mean values of BCVA and CMT were 0.42±0.32 and 0.86±0.17 (p

🔖

Cite This Article

DEMİR, M., GUVEN, D., SENDUL, S. Y., KACAR, H., ARSLAN, G. D., AKPOLAT, C. (2022). Analysis of Retinal Vessel Density and Macular Flow Area in Diabetic and Healthy Participants Using Optical Coherence Tomography Angiography. Retina-Vitreus, Cilt: 31 - Sayı: 3, 220–225. https://ajindex.com/articles/589041

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Soheilian M, Garfami KH, Ramezani A, et al. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Retina. 2012; 32:314–21
  2. Nicholson BP, Schachat AP. A review of clinical trials of anti- VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010; 248:915–30
  3. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007; 14:179–83
  4. Barham R, El Rami H, Sun JK, et al. Evidence-Based Treatment of Diabetic Macular Edema. Semin Ophthalmol. 2017; 32:56- 66
  5. Beltramo E, Porta M. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr Med Chem. 2013; 20:3218–25
  6. Ip MS, Domalpally A, Sun JK, et al. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ophthalmology. 2015; 122:367–74
  7. Sim DA, Keane PA, Zarranz-Ventura J, et al. Predictive factors for the progression of diabetic macular ischemia. Am J Ophthalmol. 2013; 156:684– 92
  8. Soares M, Neves C, Marques IP, et al. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. 2017; 101:62-8
  9. Makita S, Jaillon F, Yamanari M, et al. Comprehensive in vivo microvascular imaging of the human eye by dual-beam-scan Doppler optical coherence angiography. Opt Express 2011; 19:1271-83
  10. Spaide RF, Klancnik JM, Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015; 133:45–50
  11. Mariampillai A, Standish BA, Moriyama EH, et al. Speckle variance detection of microvasculature using swept-source optical coherence tomography. Opt Lett. 2008;33: 1530–2
  12. Enfield J, Jonathan E, Leahy M. In vivo imaging of the microcirculation of the volar forearm using correlation mapping optical coherence tomography (cmOCT). Biomed Opt Express. 2011; 2:1184–93
  13. Jia Y, Bailey ST, Hwang TS, McClintic SM, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A. 2015; 112: E2395-402. 14. de Carlo TE, Romano A, Waheed NK, et al. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous. 2015; 1:5. eCollection 15. Miura M, Makita S, Iwasaki T, et al. Three-dimensional visualization of ocular vascular pathology by